Published in Swiss Med Wkly on February 04, 2014
Aging and brain rejuvenation as systemic events. J Neurochem (2014) 0.93
In vivo assessment of behavioral recovery and circulatory exchange in the peritoneal parabiosis model. Sci Rep (2016) 0.80
Does the degree of endocrine dyscrasia post-reproduction dictate post-reproductive lifespan? Lessons from semelparous and iteroparous species. Geroscience (2017) 0.75
Effect of aging on stem cells. World J Exp Med (2017) 0.75
Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med (2000) 11.35
Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature (2005) 11.23
Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci (1996) 9.84
Little evidence for developmental plasticity of adult hematopoietic stem cells. Science (2002) 9.63
Abnormal splicing of the leptin receptor in diabetic mice. Nature (1996) 7.71
The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature (2011) 6.71
The aging of hematopoietic stem cells. Nat Med (1996) 6.67
From marrow to brain: expression of neuronal phenotypes in adult mice. Science (2000) 6.53
Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell (2013) 6.35
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci (2012) 4.95
Age-associated characteristics of murine hematopoietic stem cells. J Exp Med (2000) 4.65
Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science (1996) 4.59
Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A (1999) 4.48
Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol (2003) 3.02
Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell (2012) 2.91
Parabiosis in physiological studies. Physiol Rev (1952) 2.18
Conjoined twins in the united states, 1970-1977. Teratology (1982) 2.17
Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab (2012) 1.64
Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol (1969) 1.56
Anatomic description of conjoined twins: a plea for standardized terminology. J Pediatr Surg (1996) 1.46
The immunology of neurodegeneration. J Clin Invest (2012) 1.41
Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity. Aging Cell (2013) 1.33
The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci (2012) 1.31
Systemic regulation of the age-related decline of pancreatic β-cell replication. Diabetes (2013) 1.19
Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells. Stem Cells (2004) 1.11
Parabiosis intoxication. Proc Soc Exp Biol Med (1951) 1.04
Mortality in syngeneic rat parabionts of different chronological age. Trans N Y Acad Sci (1972) 1.00
A historical perspective on leptin. Nat Med (2010) 0.98
Systemic and acquired immune responses in Alzheimer's disease. Int Rev Neurobiol (2007) 0.95
Genetic influence on the development of renoprival hypertension in parabiotic rats. Evidence that a humoral hypertensinogenic factor is produced in kidney tissue of hypertension-prone rats. J Exp Med (1969) 0.93
Generating parabiotic zebrafish embryos for cell migration and homing studies. Nat Methods (2013) 0.85
Axonal pathfinding in the absence of normal pathways and impulse activity. J Neurosci (1984) 0.83
On the nature of parabiosis intoxication: shock as the precipitating cause. J Exp Med (1956) 0.80
Hypertension-producing factor in serum of hypertensive Dahl salt-sensitive rats. Hypertension (1984) 0.77
PARABIOSIS AS A TEST FOR CIRCULATING ANTI-BODIES IN CANCER : FIRST PAPER. J Exp Med (1909) 0.77
The occurrence of parathyroid hypertensive factor (PHF) in Dahl rats. Am J Hypertens (1993) 0.76
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med (2007) 6.80
The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature (2011) 6.71
The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest (2008) 4.09
Immune activation in brain aging and neurodegeneration: too much or too little? Neuron (2009) 3.76
Identification of a central role for complement in osteoarthritis. Nat Med (2011) 3.11
Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J Neurosci (2009) 2.82
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A (2003) 2.24
Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci (2004) 2.07
Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron (2003) 2.02
Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Invest (2006) 1.87
Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. J Clin Invest (2007) 1.78
TDP-43 frontotemporal lobar degeneration and autoimmune disease. J Neurol Neurosurg Psychiatry (2013) 1.74
All-you-can-eat: autophagy in neurodegeneration and neuroprotection. Mol Neurodegener (2009) 1.60
Genes contributing to prion pathogenesis. J Gen Virol (2008) 1.51
Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration. Proc Natl Acad Sci U S A (2006) 1.47
Highly sensitive and specific bioassay for measuring bioactive TGF-beta. BMC Cell Biol (2006) 1.42
The immunology of neurodegeneration. J Clin Invest (2012) 1.41
Global analysis of Smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury. J Immunol (2005) 1.39
Angiotensin II sustains brain inflammation in mice via TGF-beta. J Clin Invest (2010) 1.39
Chronically increased transforming growth factor-beta1 strongly inhibits hippocampal neurogenesis in aged mice. Am J Pathol (2006) 1.38
Neural progenitor cells regulate microglia functions and activity. Nat Neurosci (2012) 1.34
Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J Immunol (2007) 1.32
The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo. J Neurosci (2009) 1.31
Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J Exp Med (2013) 1.27
Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease. Neuron (2013) 1.26
Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis. J Neurosci (2011) 1.23
The role of inflammation in age-related disease. Aging (Albany NY) (2013) 1.22
Regulation of amyloid precursor protein processing by the Beclin 1 complex. PLoS One (2010) 1.22
Collagen VI protects neurons against Abeta toxicity. Nat Neurosci (2009) 1.19
Thy1-hAPP(Lond/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function. Brain Behav (2012) 1.15
Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease. J Neuroinflammation (2008) 1.13
Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease. J Biol Chem (2003) 1.08
Insights into the pathogenesis of hydrocephalus from transgenic and experimental animal models. Brain Pathol (2004) 1.08
Killing pain, killing neurons? Nat Med (2005) 0.99
Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. Am J Pathol (2010) 0.98
A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models. Curr Alzheimer Res (2006) 0.98
Immune cells may fend off Alzheimer disease. Nat Med (2007) 0.97
Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance. J Allergy Clin Immunol (2007) 0.96
Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases. J Neuroimmunol (2006) 0.96
Autophagy in dementias. Brain Pathol (2012) 0.95
Beclin 1 complex in autophagy and Alzheimer disease. Arch Neurol (2010) 0.95
Systemic and acquired immune responses in Alzheimer's disease. Int Rev Neurobiol (2007) 0.95
Blood protein signature for the early diagnosis of Alzheimer disease. Arch Neurol (2008) 0.95
Small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model. Neurobiol Aging (2013) 0.92
Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation. J Exp Med (2014) 0.92
Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome. Mol Cell Proteomics (2011) 0.92
Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patients. Am J Pathol (2012) 0.92
Modelling neuroinflammatory phenotypes in vivo. J Neuroinflammation (2004) 0.91
The circulatory systemic environment as a modulator of neurogenesis and brain aging. Autoimmun Rev (2012) 0.90
Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1. J Neurosci (2006) 0.89
Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice. J Neuroinflammation (2012) 0.88
Microglia--a wrench in the running wheel? Neuron (2008) 0.87
APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory. Neurology (2014) 0.86
Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities. Neurobiol Dis (2005) 0.86
Live imaging of Smad2/3 signaling in mouse skin wound healing. Wound Repair Regen (2007) 0.83
Chronic over-expression of TGFβ1 alters hippocampal structure and causes learning deficits. Hippocampus (2013) 0.81
Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model. Neurobiol Aging (2011) 0.80
Changes of the enteric nervous system in amyloid-β protein precursor transgenic mice correlate with disease progression. J Alzheimers Dis (2013) 0.80
Small molecule tgf-beta mimetics as potential neuroprotective factors. Curr Alzheimer Res (2005) 0.78
Bioluminescence analysis of Smad-dependent TGF-beta signaling in live mice. Methods Mol Biol (2009) 0.78
Molecular and functional dissection of TGF-beta1-induced cerebrovascular abnormalities in transgenic mice. Ann N Y Acad Sci (2002) 0.78
In vitro analysis of transforming growth factor-beta1 inhibition in novel transgenic SBE-luciferase mice. Ann Plast Surg (2007) 0.77
Sorting through the roles of beclin 1 in microglia and neurodegeneration. J Neuroimmune Pharmacol (2014) 0.77
Bioactive TGF-beta can associate with lipoproteins and is enriched in those containing apolipoprotein E3. J Neurochem (2009) 0.77
Targeting autophagy for disease therapy. Nat Biotechnol (2013) 0.76
Workshop summary: roles of the TNF family in neuronal development, function and pathology. Adv Exp Med Biol (2011) 0.75
The 1st International standard for transforming growth factor-β3 (TGF-β3). J Immunol Methods (2012) 0.75